IR surrogates | Variate type | No. MACCE Lower/Higher | Unadjusted analysis | Adjusted analysisc | ||
---|---|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |||
TyG index | Nominala | 35/152 | 4.660 (3.227–6.729) | < 0.001 | 3.805 (2.581–5.608) | < 0.001 |
 | Continuousb | – | 2.049 (1.793–2.343) | < 0.001 | 1.847 (1.564–2.181) | < 0.001 |
VAI | Nominala | 53/134 | 2.648 (1.926–3.639) | < 0.001 | 2.161 (1.559–2.996) | < 0.001 |
 | Continuousb | - | 1.517 (1.373–1.675) | < 0.001 | 1.420 (1.272–1.586) | < 0.001 |
CVAI | Nominala | 62/125 | 2.093 (1.544–2.838) | < 0.001 | 1.648 (1.203–2.258) | 0.002 |
 | Continuousb | - | 1.533 (1.339–1.756) | < 0.001 | 1.353 (1.171–1.563) | < 0.001 |
LAP | Nominala | 59/128 | 2.273 (1.670–3.094) | < 0.001 | 1.764 (1.279–2.432) | 0.001 |
 | Continuousb | - | 1.540 (1.405–1.689) | < 0.001 | 1.431 (1.289–1.589) | < 0.001 |
TG/HDL-C | Nominala | 61/126 | 2.146 (1.581–2.914) | < 0.001 | 1.757 (1.284–2.404) | < 0.001 |
 | Continuousb | – | 1.466 (1.319–1.629) | < 0.001 | 1.395 (1.241–1.569) | < 0.001 |